BHRT- The Debate Continues in Today’s WSJ Health Column

Melinda Beck’s “Health Journal” column in today’s Wall Street Journal focuses on “The 7 Things You Should Know About Hormones.“  She tries to clarify the debate over bio-identical hormone replacement therapy by offering 7 facts about bio-identicals, some of which are, well, debatable such as: don’t trust saliva tests, and hormones from compounding pharmacies aren’t safer than conventional HRT.  I don’t know if those statements are true, but I do know that there is still principled debate on both sides.

Melinda Beck quotes a physician-spokeswoman representing the Endocrine Society who weighs in against bio-identicals: “women may be putting themselves at much higher levels of risk.”  I wish Ms. Beck would have pointed out that Wyeth Pharmaceuticals, the maker of Premarin and Prempro,  (the most widely prescribed hormones until the WHI study was prematurely stopped), is a Corporate Liaison Board member of The Endocrine Society and was a “Leadership Donor” in 2002, according to Compounding Facts.Org (written by an organization of compounding pharmacists).

That doesn’t negate the spokesperson’s statement.  A connection with Wyeth just colors the debate and makes us wonder, don’t you think?